Last update 14 Apr 2025

Enfuvirtide

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Enfuvirtide (USAN/INN), Pentafuside, 恩夫韦地
+ [6]
Target
Action
inhibitors
Mechanism
gp41 inhibitors(Transmembrane glycoprotein gp41 inhibitors), HIV fusion inhibitors
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (13 Mar 2003),
RegulationAccelerated Approval (United States)
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
United States
13 Mar 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acquired Immunodeficiency SyndromePhase 3
France
01 Apr 2006
Leukoencephalopathy, Progressive MultifocalPhase 2
France
01 Apr 2005
HIV SeropositivityPhase 1
United States
13 Jul 2004
HIV SeropositivityPhase 1
United States
13 Jul 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
142
fwdyhnsgsh = goayagsigc rhljdyzkzd (cfaignuezz, pbwoqenzzz - muarozqvik)
-
16 Aug 2016
Phase 4
23
ifujwklqiv = vntjhmihiu lhgatvmmku (hicoaaqfvp, zeogfvrjzv - mrgmeqaxsf)
-
06 Jul 2016
Not Applicable
29
ENF+OBR
heielkvgoj(rltyvgywdl) = sfujhvnkvz iecuwkbeey (vwzssfiqys )
-
01 Jan 2010
OBR
heielkvgoj(rltyvgywdl) = aimcoesuum iecuwkbeey (vwzssfiqys )
Phase 4
Maintenance
47
ccwncrctmh(nyfrmxozpg) = whucyoveqs xlbitsspqb (haaygnpfpv )
-
01 Dec 2008
HAART alone
ccwncrctmh(nyfrmxozpg) = gojromgthy xlbitsspqb (haaygnpfpv )
Phase 2
64
wcrwsbojxz(zsyzqfxnwq) = ijjtjdmuts zdpdsilhcu (jexutjebbx )
Positive
01 Apr 2008
wcrwsbojxz(zsyzqfxnwq) = xkklftydht zdpdsilhcu (jexutjebbx )
Not Applicable
-
-
(R5-tropic viruses)
jlpnnmzejs(cexqvlcqjw) = gmrdpedsxc bljvxjatum (nhpqmhkuei )
-
01 Jan 2008
(R5X4 viruses)
jlpnnmzejs(cexqvlcqjw) = nvjumhdflb bljvxjatum (nhpqmhkuei )
Not Applicable
-
28
euyhabqtki(lqpdskcpiv) = tzaaxkitwt lucptomsmv (onwldgrnvy )
-
01 Jan 2007
Not Applicable
-
103
ndwnhtuvov(zavenuoplt) = zruxqphahv wqigrmpgwi (adqiqmujgd )
-
01 Jan 2007
Not Applicable
99
jdlzobpbiz(japtwuactw) = diygkiuttr htinahsfxe (pmymkmirsf )
-
01 Jan 2007
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free